Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS

被引:66
作者
Biber, A [1 ]
Koch, E [1 ]
机构
[1] Dr W Schwabe GmbH & Co, Res & Dev, D-76209 Karlsruhe, Germany
关键词
D O I
10.1055/s-2006-960467
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The bioavailability of ginkgolides A, B and bilobalide was studied in rats after single oral administration of 30, 55 and 100 mg/kg Ginkgo extract EGb 761(R). The plasma levels of the terpene lactones were measured by a specific GC/MS method. The pharmacokinetics of the mentioned substances were found to be dose-linear. For the lowest dose maximum concentrations were 68, 40 and 159 ng/ml and half-lives 1.7, 2.0 and 2.2 h for ginkgolide A, B and bilobalide, respectively, Clearance values ranged from 24.2 to 37.6 ml/min/kg.
引用
收藏
页码:192 / 193
页数:2
相关论文
共 4 条
[1]  
*CPMP, III5489 CPMP
[2]  
FOURTILLAN JB, 1995, THERAPIE, V50, P137
[3]   SPECIFIC RECEPTOR-SITES FOR 1-O-ALKYL-2-O-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE (PLATELET ACTIVATING FACTOR) ON RABBIT PLATELET AND GUINEA-PIG SMOOTH-MUSCLE MEMBRANES [J].
HWANG, SB ;
LEE, CSC ;
CHEAH, MJ ;
SHEN, TY .
BIOCHEMISTRY, 1983, 22 (20) :4756-4763
[4]   The bioavailability of ginkgolides in Ginkgo biloba extracts [J].
Li, CL ;
Wong, YY .
PLANTA MEDICA, 1997, 63 (06) :563-565